The research advancements made at the Memory & Aging Program towards a future without Alzheimer's disease would not be possible without our courageous study participants and dedicated compassionate donors. Research study participants have the chance to be part of scientific research that may lead to a preventative treatment for Alzheimer’s disease.
Join the Butler Alzheimer’s Prevention Registry
We have a 25 year history of excellence in clinical care, training, and research. We work hand in hand with passionate research volunteers, patients and their families to find a preventative treatment for Alzheimer’s disease. Our goal is to encourage people to join research studies for the prevention and early treatment of Alzheimer’s disease.
Follow this link to learn more about the registry or other research studies, or contact us by phone at (401) 455-6403 or by email at email@example.com.
Opening & Enrolling Research Studies for Alzheimer’s Disease
The Alzheimer's disease research studies at Butler Hospital listed below are active and open to enrollment. Please click the links below to learn more about specific trials.
These enrolling studies are for fairly healthy adults who are 65-85 years old with normal mental and thinking abilities. Individuals are not required to have a family history of Alzheimer’s disease to participate.
Studies for People with Mild Memory Impairment or Mild Alzheimer’s Disease
These enrolling studies are for adults 50-85 years old who may have mild memory impairment.
Studies for People with a Family Mutation
The DIAN study is for adults who have a biological parent that carries a rare genetic mutation known to cause an early form of Alzheimer’s.
Studies Developing New Brain Scans for Early Detection
These enrolling studies are evaluating investigational agents/tracers to identify the presence of tau protein deposits, which are often found in individuals with Alzheimer’s disease and other neurological conditions.
Other Studies of Dementia
The following studies are for adults 60 years or older with normal pressure hydrocephalus and for adults 65 years or older who have progressively mild cognitive impairment or dementia symptoms of uncertain cause.